Related Articles
MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr-/-Apob100/100 mouse
Tesaglitazar ameliorates non-alcoholic fatty liver disease and atherosclerosis development in diabetic low-density lipoprotein receptor-deficient mice
Amygdalin ameliorates the progression of atherosclerosis in LDL receptor‑deficient mice
Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response
Evolution of angiotensin II-mediated atherosclerosis in ApoE KO mice